BCAX position history
The shares of Bicara Therapeutics (BCAX) that Palo Alto Investors LP reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2025 Q4: 298,575 shares, $5M, 0.70% of portfolio, New
- 2026 Q1: 550,408 shares, $11M, 1.7% of portfolio, Add +84.3%
- 2026 Q2: 550,408 shares, $16M, 2.3% of portfolio
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|